Document Detail


Hydroquinone Therapy for Post-inflammatory Hyperpigmentation Secondary to Acne: Not Just Prescribable by Dermatologists.
MedLine Citation:
PMID:  22002814     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Post-inflammatory hyperpigmentation after acne can be as troublesome as the acne itself. Hydroquinone, a tyrosinase inhibitor, in a 4% cream can be used safely twice daily for up to 6 months to treat post-inflammatory hyperpigmentation. The efficacy of this treatment can be enhanced by using a retinoid nightly and a mid-potent steroid, which is applied twice daily for 2 weeks, then at weekends only. Combination creams help with compliance, but often lack the strongest individual ingredients. Because steroids should not be applied to the face for prolonged periods, care should be taken when a hydroquinone cream containing a steroid is chosen. If post-inflammatory hyperpigmentation consists of a few lesions, spot therapy is useful. If post-inflammatory hyperpigmentation consists of many lesions, field therapy is favored. Safety concerns with hydroquinone consist only of occasional irritation, which can be suppressed with topical steroid or a short drug holiday. Physicians should feel comfortable to use hydroquinone without consulting a dermatologist. Key words: hydroquinone; acne; adolescent; post-inflammatory hyperpigmentation.
Authors:
Mekhala Chandra; Jacob Levitt; Cara A Pensabene
Related Documents :
6365464 - Clinical evaluation of piroxicam in acute musculoskeletal injuries seen in general prac...
24083734 - Pyogenic liver abscess as a warning sign for primary liver cancer: a nationwide populat...
17470884 - Effect of short-term postoperative celecoxib administration on patient outcome after ou...
16329054 - Comparison of the efficacy and safety of two formulations of diclofenac sodium 0.1% eye...
11270304 - Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea p...
11756944 - Intravenous immunoglobulin therapy for patients with pemphigus foliaceus unresponsive t...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-17
Journal Detail:
Title:  Acta dermato-venereologica     Volume:  -     ISSN:  0001-5555     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370310     Medline TA:  Acta Derm Venereol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Dermatology, The Mount Sinai School of Medicine, New York, NY 10025, USA. E-mail: mekhala.chandra@gmail.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Over-expression of Adamts1 in mice alters bone mineral density.
Next Document:  Elevated effector cell sensitivity to Treg-cell suppression that is not associated with reduced Th17...